AI-generated summary
The authors randomized 60 outpatients with head and neck cancer receiving radiotherapy to either low level laser therapy or sham laser. The laser group showed lower oral mucositis and pain and higher salivary flow at follow-up sessions, which the authors report as statistically significant. The authors suggest laser therapy may be a useful adjuvant for controlling these complications.
- Participants
- 60
- Who or what was studied
- Outpatients with head and neck cancer undergoing radiotherapy at a cancer hospital
- Limits stated in the abstract
- The abstract does not report the wavelength or dose parameters in nanometers beyond naming an InGaAlP laser, and it does not describe blinding or details of the sham procedure.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Oral mucositis, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.